Lyell Immunopharma, Inc. Revenue 2019–2025
Lyell Immunopharma, Inc. annual/quarterly revenue history and growth rate from 2019 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Lyell Immunopharma, Inc. revenue for the quarter ending March 31, 2026 was 2000, a 71.43% decrease year-over-year.
- Lyell Immunopharma, Inc. revenue for the twelve months ending March 31, 2026 was 32000, a 57.33% decrease year-over-year.
- Lyell Immunopharma, Inc. annual revenue for 2025 was 36000, a 40.98% decrease from 2024.
- Lyell Immunopharma, Inc. annual revenue for 2024 was 61000, a 53.08% decrease from 2023.
- Lyell Immunopharma, Inc. annual revenue for 2023 was 130000, a 99.85% decrease from 2022.
- Lyell Immunopharma, Inc. annual revenue for 2022 was 84.7 M.
Lyell Immunopharma, Inc. (LYEL) — Frequently Asked Questions
Lyell Immunopharma, Inc. (LYEL) is a publicly traded US company. It has a market capitalization of $235M. In fiscal 2025 it reported revenue of $36,000 and net income of -$274M. Explore LYEL's stock price, financial statements, earnings history, margins and key ratios below.
What is Lyell Immunopharma, Inc.'s market cap?
Lyell Immunopharma, Inc. (LYEL) has a market capitalization of $235M.
What is the LYEL stock price?
LYEL trades at $13.72 (+3.78% on the day).
How much revenue does Lyell Immunopharma, Inc. make?
Lyell Immunopharma, Inc. reported revenue of $36,000 in fiscal 2025.
Is LYEL profitable?
In fiscal 2025, Lyell Immunopharma, Inc. reported net income of -$274M.